Table 2.
Correlation of HAS1 and HAS2 with clinical and histopathological factors
| Variable | HAS1 Coverage | HAS1 Intensity | HAS2 Coverage | HAS2 Intensity |
|---|---|---|---|---|
| Stage | p = 0.006 | ns | ns | p = 0.047 |
| pT1, pT4 or pN1- | ||||
| Melanoma related death | p = 0.007 | ns | p = 0.001 | p = 0.016 |
| Recurrence | p = 0.021 | ns | p = 0.007 | ns |
| Regional recurrence | p = 0.006 | p = 0.023 | p = 0.007 | ns |
| Distant recurrence | p = 0.012 | ns | p = 0.001 | p = 0.004 |
| Genre | ns | ns | ns | ns |
| Age | ns | ns | ns | ns |
| Ulceration | ns | ns | ns | ns |
| TIL (low / moderate / high) | ns | ns | p = 0.036 | p = 0.040 |
| Mitotic count (mitosis/mm2) | ns | ns | ns | p = 0.018 |
| Horizontal diameter of melanoma (mm) | ns | ns | p = 0.002 | p =0.042 |
| Growth type | ||||
| Nodular | ns | ns | ns | p = 0.001 |
Stage = pT1, pT4 or pN1-. TIL = tumor-infiltrating lymphocytes (evaluated either low, moderate or high amount). Mitosis = mitosis/mm2, horizontal tumor diameter (mm)